Diversified Healthcare Trust (DHC) Stock Forecast, Price Target & Predictions
DHC Stock Forecast
Diversified Healthcare Trust stock forecast is as follows: an average price target of $6.00 (represents a 69.01% upside from DHC’s last price of $3.55) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
DHC Price Target
The average price target for Diversified Healthcare Trust (DHC) is $6.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 69.01% upside from DHC's last price of $3.55.
DHC Analyst Ratings
According to 2 Wall Street analysts, Diversified Healthcare Trust's rating consensus is 'Buy'. The analyst rating breakdown for DHC stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 1 'Strong Sell' (50.00%).
Diversified Healthcare Trust Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 05, 2024 | Bryan Maher | B.Riley Financial | $6.00 | $3.13 | 91.39% | 69.01% |
The latest Diversified Healthcare Trust stock forecast, released on Aug 05, 2024 by Bryan Maher from B.Riley Financial, set a price target of $6.00, which represents a 91.39% increase from the stock price at the time of the forecast ($3.13), and a 69.01% increase from DHC last price ($3.55).
Diversified Healthcare Trust Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $6.00 | $6.00 |
| Last Closing Price | $3.55 | $3.55 | $3.55 |
| Upside/Downside | -100.00% | 69.01% | 69.01% |
In the current month, the average price target of Diversified Healthcare Trust stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Diversified Healthcare Trust's last price of $3.55. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 05, 2024 | B. Riley | Buy | Buy | Hold |
| Apr 26, 2022 | Zacks Investment Research | - | Strong Sell | Downgrade |
Diversified Healthcare Trust's last stock rating was published by B. Riley on Aug 05, 2024. The company gave DHC a "Buy" rating, the same as its previous rate.
Diversified Healthcare Trust Financial Forecast
Diversified Healthcare Trust Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $1.51B | $356.52M | $346.22M | $346.03M | $336.88M | $322.92M | - | $310.73M | $336.73M | $337.42M | $346.34M | $362.72M | $384.91M | $394.34M | $410.31M | $442.47M | $256.04M | $255.83M | $262.00M | $266.29M | $278.97M | $277.25M |
| Avg Forecast | $414.10M | $412.20M | $410.60M | $404.80M | $390.31M | $379.15M | $372.13M | $370.65M | $360.99M | $359.78M | $353.15M | $341.33M | $330.40M | $320.79M | $319.10M | $319.84M | $336.01M | $348.61M | $365.93M | $359.18M | $388.92M | $397.14M | $419.43M | $436.06M | $250.97M | $255.23M | $255.77M | $268.21M | $176.19M | $74.63M |
| High Forecast | $416.67M | $414.75M | $413.14M | $407.31M | $392.73M | $381.50M | $374.44M | $372.94M | $363.23M | $362.01M | $355.34M | $343.44M | $332.45M | $322.78M | $319.10M | $320.60M | $336.81M | $349.44M | $366.80M | $360.03M | $389.84M | $398.08M | $420.42M | $437.09M | $251.57M | $255.84M | $256.38M | $268.84M | $211.43M | $89.56M |
| Low Forecast | $411.53M | $409.65M | $408.06M | $402.29M | $387.89M | $376.80M | $369.82M | $368.35M | $358.76M | $357.55M | $350.96M | $339.21M | $328.36M | $318.80M | $319.10M | $318.60M | $334.71M | $347.26M | $364.51M | $357.79M | $387.41M | $395.60M | $417.80M | $434.36M | $250.00M | $254.24M | $254.78M | $267.17M | $140.95M | $59.70M |
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 7 |
| Surprise % | - | - | - | - | - | - | - | - | 4.19% | 0.99% | 0.98% | 1.01% | 1.02% | 1.01% | - | 0.97% | 1.00% | 0.97% | 0.95% | 1.01% | 0.99% | 0.99% | 0.98% | 1.01% | 1.02% | 1.00% | 1.02% | 0.99% | 1.58% | 3.71% |
Diversified Healthcare Trust's average Quarter revenue forecast for Mar 24 based on 0 analysts is $370.65M, with a low forecast of $368.35M, and a high forecast of $372.94M. DHC's average Quarter revenue forecast represents a -75.51% decrease compared to the company's last Quarter revenue of $1.51B (Dec 23).
Diversified Healthcare Trust EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 7 |
| EBITDA | - | - | - | - | - | - | - | - | $1.19B | $-46.49M | $-51.78M | $58.27M | $55.12M | $31.79M | - | $35.21M | $503.46M | $42.60M | $99.67M | $57.11M | $105.58M | $16.92M | $86.02M | $117.50M | $59.69M | $86.81M | $81.52M | $146.53M | $161.47M | $239.39M |
| Avg Forecast | $131.61M | $131.01M | $130.50M | $128.66M | $124.05M | $120.51M | $118.28M | $117.80M | $114.74M | $114.35M | $112.24M | $108.48M | $105.01M | $119.49M | $101.42M | $101.65M | $106.80M | $127.80M | $54.82M | $44.70M | $159.81M | $13.75M | $86.02M | $264.37M | $79.77M | $81.12M | $81.29M | $146.53M | $74.01M | $23.72M |
| High Forecast | $132.43M | $131.82M | $131.31M | $129.46M | $124.82M | $121.25M | $119.01M | $118.53M | $115.45M | $115.06M | $112.94M | $109.16M | $105.66M | $143.39M | $101.42M | $101.90M | $107.05M | $153.36M | $65.78M | $53.63M | $191.77M | $16.50M | $103.23M | $317.25M | $79.96M | $81.31M | $81.49M | $175.84M | $88.81M | $28.46M |
| Low Forecast | $130.80M | $130.20M | $129.69M | $127.86M | $123.28M | $119.76M | $117.54M | $117.07M | $114.02M | $113.64M | $111.55M | $107.81M | $104.36M | $95.59M | $101.42M | $101.26M | $106.38M | $102.24M | $43.85M | $35.76M | $127.84M | $11.00M | $68.82M | $211.50M | $79.46M | $80.81M | $80.98M | $117.23M | $59.20M | $18.98M |
| Surprise % | - | - | - | - | - | - | - | - | 10.41% | -0.41% | -0.46% | 0.54% | 0.52% | 0.27% | - | 0.35% | 4.71% | 0.33% | 1.82% | 1.28% | 0.66% | 1.23% | 1.00% | 0.44% | 0.75% | 1.07% | 1.00% | 1.00% | 2.18% | 10.09% |
0 analysts predict DHC's average Quarter EBITDA for Mar 24 to be $117.80M, with a high of $118.53M and a low of $117.07M. This is -90.14% lower than Diversified Healthcare Trust's previous annual EBITDA (Dec 23) of $1.19B.
Diversified Healthcare Trust Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 7 |
| Net Income | - | - | - | - | - | - | - | - | $-102.56M | $-65.78M | $-72.57M | $-52.01M | $-62.69M | $-83.62M | - | $240.42M | $366.76M | $-89.34M | $-34.22M | $-67.50M | $-16.23M | $-106.89M | $-26.07M | $9.73M | $-51.70M | $-29.39M | $-37.23M | $30.08M | $45.80M | $123.59M |
| Avg Forecast | $-38.29M | $-43.08M | $-47.87M | $-50.26M | $-57.44M | $-62.22M | $-67.01M | $1.17B | $-59.83M | $-50.26M | $-52.65M | $1.26B | $-67.01M | $-250.61M | $-69.37M | $1.34B | $288.04M | $-268.03M | $-18.82M | $-52.83M | $-24.56M | $-86.85M | $-26.07M | $21.90M | $6.38M | $-158.71M | $-143.60M | $30.08M | $20.99M | $190.68M |
| High Forecast | $-37.98M | $-42.73M | $-47.48M | $-49.85M | $-56.98M | $-61.72M | $-66.47M | $1.41B | $-59.35M | $-49.85M | $-52.23M | $1.51B | $-66.47M | $-200.49M | $-69.37M | $1.61B | $345.64M | $-214.42M | $-15.06M | $-42.26M | $-19.65M | $-69.48M | $-20.86M | $26.28M | $6.40M | $-126.96M | $-114.88M | $36.10M | $25.19M | $228.81M |
| Low Forecast | $-38.60M | $-43.43M | $-48.25M | $-50.66M | $-57.90M | $-62.72M | $-67.55M | $939.52M | $-60.31M | $-50.66M | $-53.08M | $1.00B | $-67.55M | $-300.73M | $-69.37M | $1.07B | $230.43M | $-321.63M | $-22.59M | $-63.40M | $-29.48M | $-104.22M | $-31.29M | $17.52M | $6.35M | $-190.45M | $-172.32M | $24.07M | $16.80M | $152.54M |
| Surprise % | - | - | - | - | - | - | - | - | 1.71% | 1.31% | 1.38% | -0.04% | 0.94% | 0.33% | - | 0.18% | 1.27% | 0.33% | 1.82% | 1.28% | 0.66% | 1.23% | 1.00% | 0.44% | -8.11% | 0.19% | 0.26% | 1.00% | 2.18% | 0.65% |
Diversified Healthcare Trust's average Quarter net income forecast for Jul 22 is $-69.37M, with a range of $-69.37M to $-69.37M. DHC's average Quarter net income forecast represents a -128.85% decrease compared to the company's last Quarter net income of $240.42M (Mar 22).
Diversified Healthcare Trust SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 7 |
| SG&A | - | - | - | - | - | - | - | - | - | $6.95M | $7.28M | $5.87M | $5.76M | $6.18M | - | $7.29M | $8.55M | $8.87M | $9.13M | $7.54M | $7.46M | $6.99M | $7.31M | $77.26M | $78.24M | $82.97M | $82.79M | $82.05M | $102.69M | $101.38M |
| Avg Forecast | $9.09M | $9.05M | $9.02M | $8.89M | $8.57M | $8.32M | $8.17M | $35.59M | $7.93M | $7.90M | $7.75M | $38.06M | $7.25M | $24.88M | $7.01M | $40.70M | $6.74M | $26.61M | $5.02M | $5.90M | $11.29M | $5.68M | $7.31M | $173.84M | $5.51M | $5.60M | $5.62M | $82.05M | $47.07M | $1.64M |
| High Forecast | $9.15M | $9.11M | $9.07M | $8.94M | $8.62M | $8.38M | $8.22M | $42.70M | $7.98M | $7.95M | $7.80M | $45.67M | $7.30M | $29.86M | $7.01M | $48.85M | $8.08M | $31.93M | $6.02M | $7.08M | $13.55M | $6.81M | $8.77M | $208.61M | $5.52M | $5.62M | $5.63M | $98.46M | $56.48M | $1.97M |
| Low Forecast | $9.04M | $8.99M | $8.96M | $8.83M | $8.52M | $8.27M | $8.12M | $28.47M | $7.88M | $7.85M | $7.71M | $30.45M | $7.21M | $19.90M | $7.01M | $32.56M | $5.39M | $21.29M | $4.02M | $4.72M | $9.03M | $4.54M | $5.85M | $139.07M | $5.49M | $5.58M | $5.59M | $65.64M | $37.65M | $1.31M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.88% | 0.94% | 0.15% | 0.79% | 0.25% | - | 0.18% | 1.27% | 0.33% | 1.82% | 1.28% | 0.66% | 1.23% | 1.00% | 0.44% | 14.20% | 14.81% | 14.74% | 1.00% | 2.18% | 61.87% |
Diversified Healthcare Trust's average Quarter SG&A projection for Dec 23 is $7.93M, based on 1 Wall Street analysts, with a range of $7.88M to $7.98M. The forecast indicates a 13.98% rise compared to DHC last annual SG&A of $6.95M (Sep 23).
Diversified Healthcare Trust EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 7 |
| EPS | - | - | - | - | - | - | - | - | $-0.43 | $-0.28 | $-0.30 | $-0.22 | $-0.26 | $-0.35 | - | $1.01 | $1.54 | $-0.38 | $-0.14 | $-0.28 | $-0.07 | $-0.45 | $-0.11 | $0.04 | $-0.22 | $-0.12 | $-0.16 | $0.13 | $0.19 | $0.52 |
| Avg Forecast | $-0.16 | $-0.18 | $-0.20 | $-0.21 | $-0.24 | $-0.26 | $-0.28 | $-0.28 | $-0.25 | $-0.21 | $-0.22 | $-0.23 | $-0.28 | $-0.25 | $-0.29 | $-0.26 | $-0.24 | $-0.23 | $-0.24 | $-0.25 | $-0.23 | $-0.14 | $-0.15 | $-0.14 | $0.03 | $0.02 | $0.07 | $0.10 | $0.05 | $0.22 |
| High Forecast | $-0.16 | $-0.18 | $-0.20 | $-0.21 | $-0.24 | $-0.26 | $-0.28 | $-0.28 | $-0.25 | $-0.21 | $-0.22 | $-0.23 | $-0.28 | $-0.25 | $-0.29 | $-0.26 | $-0.24 | $-0.23 | $-0.24 | $-0.25 | $-0.23 | $-0.14 | $-0.15 | $-0.14 | $0.03 | $0.02 | $0.07 | $0.10 | $0.07 | $0.26 |
| Low Forecast | $-0.16 | $-0.18 | $-0.20 | $-0.21 | $-0.24 | $-0.26 | $-0.28 | $-0.28 | $-0.25 | $-0.21 | $-0.22 | $-0.23 | $-0.28 | $-0.25 | $-0.29 | $-0.26 | $-0.24 | $-0.23 | $-0.24 | $-0.25 | $-0.23 | $-0.14 | $-0.15 | $-0.15 | $0.03 | $0.02 | $0.07 | $0.10 | $0.04 | $0.17 |
| Surprise % | - | - | - | - | - | - | - | - | 1.72% | 1.33% | 1.36% | 0.96% | 0.93% | 1.40% | - | -3.88% | -6.42% | 1.65% | 0.58% | 1.14% | 0.30% | 3.16% | 0.73% | -0.28% | -8.25% | -7.42% | -2.36% | 1.34% | 3.80% | 2.36% |
According to 0 Wall Street analysts, Diversified Healthcare Trust's projected average Quarter EPS for Jul 22 is $-0.29, with a low estimate of $-0.29 and a high estimate of $-0.29. This represents a -128.71% decrease compared to DHC previous annual EPS of $1.01 (Mar 22).
Diversified Healthcare Trust Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| DHC | Diversified Healthcare Trust | $3.55 | $6.00 | 69.01% | Buy |
| HR | Healthcare Realty Trust | $18.78 | $19.00 | 1.17% | Buy |
| VTR | Ventas | $65.06 | $60.97 | -6.29% | Buy |
| SBRA | Sabra Health Care REIT | $18.59 | $17.29 | -6.99% | Hold |
| OHI | Omega Healthcare Investors | $40.62 | $35.73 | -12.04% | Buy |
| CTRE | CareTrust REIT | $31.08 | $25.50 | -17.95% | Buy |
| NHI | National Health Investors | $85.05 | $67.25 | -20.93% | Hold |
DHC Forecast FAQ
Is Diversified Healthcare Trust a good buy?
Yes, according to 2 Wall Street analysts, Diversified Healthcare Trust (DHC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of DHC's total ratings.
What is DHC's price target?
Diversified Healthcare Trust (DHC) average price target is $6 with a range of $6 to $6, implying a 69.01% from its last price of $3.55. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Diversified Healthcare Trust stock go up soon?
According to Wall Street analysts' prediction for DHC stock, the company can go up by 69.01% (from the last price of $3.55 to the average price target of $6), up by 69.01% based on the highest stock price target, and up by 69.01% based on the lowest stock price target.
Can Diversified Healthcare Trust stock reach $5?
DHC's average twelve months analyst stock price target of $6 supports the claim that Diversified Healthcare Trust can reach $5 in the near future.
What are Diversified Healthcare Trust's analysts' financial forecasts?
Diversified Healthcare Trust's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $1.51B (high $1.52B, low $1.5B), average EBITDA is $480.64M (high $483.62M, low $477.66M), average net income is $987.73M (high $1.22B, low $751.34M), average SG&A $60.65M (high $67.92M, low $53.38M), and average EPS is $-1.06 (high $-1.051, low $-1.069). DHC's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.64B (high $1.65B, low $1.63B), average EBITDA is $521.79M (high $525.02M, low $518.55M), average net income is $-179M (high $-178M, low $-181M), average SG&A $36.05M (high $36.27M, low $35.82M), and average EPS is $-0.75 (high $-0.744, low $-0.756).
Did the DHC's actual financial results beat the analysts' financial forecasts?
Based on Diversified Healthcare Trust's last annual report (Dec 2023), the company's revenue was $1.41B, which missed the average analysts forecast of $1.42B by -0.35%. Apple's EBITDA was $-180M, missing the average prediction of $449.81M by -140.10%. The company's net income was $-272M, missing the average estimation of $1.09B by -124.90%. Apple's SG&A was $26.13M, missing the average forecast of $61.64M by -57.61%. Lastly, the company's EPS was $-1.14, beating the average prediction of $-0.91 by 25.27%. In terms of the last quarterly report (Dec 2023), Diversified Healthcare Trust's revenue was $1.51B, beating the average analysts' forecast of $360.99M by 319.24%. The company's EBITDA was $1.19B, beating the average prediction of $114.74M by 940.82%. Diversified Healthcare Trust's net income was $-103M, beating the average estimation of $-59.832M by 71.42%. The company's SG&A was $0, missing the average forecast of $7.93M by -100.00%. Lastly, the company's EPS was $-0.43, beating the average prediction of $-0.25 by 72.00%